FLT3 and acute myeloid leukemia: Finally, targeting the mitochondrial ATP-synthase (sometimes called complex V) with oligomycin A greatly sensitized leukemia cells to tyrosine kinase inhibitors in FLT3-dependent AML cells, both in vitro and in vivo [89].